跳至主要内容
临床试验/NL-OMON50136
NL-OMON50136已完成不适用

TitelSymptom monitoring with patient-reported outcomes using a web application among lung cancer patients in the Netherlands (SYMPRO-LUNG ) - SYMPRO-Lung

Vrije Universiteit Medisch Centrum0 个研究点目标入组 584 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
584

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Cytological or histologically proven or radiological suspect small or non-small
  • cell lung cancer patients that are starting treatment with radiotherapy,
  • surgery, chemotherapy, immunotherapy or targeted therapy, or a combination.
  • Other inclusion criteria are 18 years and older, ECOG Performance Status
  • classification should be 0,1 or 2 and access to internet.

排除标准

  • Patients who are participants of a treatment study or when their life
  • expectancy at moment of inclusion is shorter than 15 weeks. The patient*s
  • treatment and follow up will have to remain in an affiliated hospital

研究者

相似试验

TitelSymptom monitoring with patient-reported... | 临床试验